Lymphocyte proliferation in immune-mediated diseases

Trends in Immunology

Volumn 30, Issue 9, 2009, Pages 430-438

  Datta, Shrimati ^a   Sarvetnick, Nora ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIRETROVIRUS AGENT; CYCLOPHOSPHAMIDE; CYTOKINE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 15; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 7; INTERLEUKIN 7 ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL THERAPY; COLITIS; GOODPASTURE SYNDROME; GRAFT REJECTION; GRAVES DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMEOSTASIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MELANOMA; MULTIPLE SCLEROSIS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; TUMOR IMMUNITY;

ANIMALS; AUTOIMMUNITY; CELL PROLIFERATION; CYTOKINES; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOLOGIC SURVEILLANCE; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 68949166331     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2009.06.002     Document Type: Review

References (91)

1. Jameson S.C. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol 2 8 (2002) 547-556
2. Li L., and Boussiotis V.A. Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications. J Mol Med 84 11 (2006) 887-899
3. Min B., et al. Neonates support lymphopenia-induced proliferation. Immunity 18 1 (2003) 131-140
4. Jameson S.C. T cell homeostasis: keeping useful T cells alive and live T cells useful. Semin Immunol 17 3 (2005) 231-237
5. Hamilton S.E., et al. The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat Immunol 7 5 (2006) 475-481
6. Goldrath A.W., et al. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 192 4 (2000) 557-564
7. Cho B.K., et al. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med 192 4 (2000) 549-556
8. Baccala R., and Theofilopoulos A.N. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol 26 1 (2005) 5-8
9. Khoruts A., and Fraser J.M. A causal link between lymphopenia and autoimmunity. Immunol Lett 98 1 (2005) 23-31
10. Krupica Jr. T., et al. Autoimmunity during lymphopenia: a two-hit model. Clin Immunol 120 2 (2006) 121-128
11. Marleau A.M., and Sarvetnick N. T cell homeostasis in tolerance and immunity. J Leukoc Biol 78 3 (2005) 575-584
12. Schulze-Koops H. Lymphopenia and autoimmune diseases. Arthritis Res Ther 6 4 (2004) 178-180
13. Shiow L.R., et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440 7083 (2006) 540-544
14. Liu Y., and Zheng P. CD24: a genetic checkpoint in T cell homeostasis and autoimmune diseases. Trends Immunol 28 7 (2007) 315-320
15. Le Saout C., et al. Memory-like CD8+ and CD4+ T cells cooperate to break peripheral tolerance under lymphopenic conditions. Proc Natl Acad Sci U S A 105 49 (2008) 19414-19419
16. Long B., et al. Lymphopenia-driven CD8(+) T cells are resistant to antigen-induced tolerance in NOD.scid mice. Eur J Immunol 36 8 (2006) 2003-2012
17. Min B., et al. Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. J Immunol 174 10 (2005) 6039-6044
18. Winstead C.J., et al. Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells. J Immunol 180 11 (2008) 7305-7317
19. Tajima M., et al. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J Exp Med 205 5 (2008) 1019-1027
20. Williams K.M., et al. T cell immune reconstitution following lymphodepletion. Semin Immunol 19 5 (2007) 318-330
21. Min B., et al. Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc Natl Acad Sci U S A 101 11 (2004) 3874-3879
22. Bourgeois C., and Stockinger B. CD25+CD4+ regulatory T cells and memory T cells prevent lymphopenia-induced proliferation of naive T cells in transient states of lymphopenia. J Immunol 177 7 (2006) 4558-4566
23. Kieper W.C., et al. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J Immunol 174 6 (2005) 3158-3163
24. Arnold B., et al. Control of peripheral T-lymphocyte tolerance in neonates and adults. Trends Immunol 26 8 (2005) 406-411
25. Dujardin H.C., et al. Regulatory potential and control of Foxp3 expression in newborn CD4+ T cells. Proc Natl Acad Sci U S A 101 40 (2004) 14473-14478
26. Adkins B., et al. Neonatal adaptive immunity comes of age. Nat Rev Immunol 4 7 (2004) 553-564
27. Alferink J., et al. Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking. Science 282 5392 (1998) 1338-1341
28. Reveille J.D., and Williams F.M. Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. Best Pract Res Clin Rheumatol 20 6 (2006) 1159-1179
29. Zandman-Goddard G., and Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 1 6 (2002) 329-337
30. Morrissey P.J., et al. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 178 1 (1993) 237-244
31. Monti P., et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest 118 5 (2008) 1806-1814
32. Calzascia T., et al. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc Natl Acad Sci U S A 105 8 (2008) 2999-3004
33. Zou L., et al. Defective positive selection results in T cell lymphopenia and increased autoimmune diabetes in ADAP-deficient BDC2. 5-C57BL/6 mice. Eur J Immunol 38 4 (2008) 986-994
34. Koetz K., et al. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 97 16 (2000) 9203-9208
35. Jang E., et al. Prevention of spontaneous arthritis by inhibiting homeostatic expansion of autoreactive CD4+ T cells in the K/BxN mouse model. Arthritis Rheum 54 2 (2006) 492-498
36. Sawa S., et al. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. J Exp Med 203 6 (2006) 1459-1470
37. Khiong K., et al. Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J Clin Invest 117 5 (2007) 1270-1281
38. Baccala R., et al. Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives. Springer Semin Immunopathol 27 1 (2005) 75-85
39. Dummer W., et al. T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest 110 2 (2002) 185-192
40. Dudley M.E., et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23 10 (2005) 2346-2357
41. Brown I.E., et al. Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection. J Immunol 177 7 (2006) 4521-4529
42. Gattinoni L., et al. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med 202 7 (2005) 907-912
43. Klebanoff C.A., et al. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 211 (2006) 214-224
44. Wrzesinski C., et al. Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells. J Clin Invest 117 2 (2007) 492-501
45. Yee C., et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med 192 11 (2000) 1637-1644
46. Palmer D.C., et al. Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc Natl Acad Sci U S A 105 23 (2008) 8061-8066
47. Klein O., et al. Melan-A-specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4. Clin Cancer Res (2009)
48. Goldrath A.W., et al. Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 195 12 (2002) 1515-1522
49. Seddon B., et al. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 4 7 (2003) 680-686
50. Teague R.M., et al. Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors. Nat Med 12 3 (2006) 335-341
51. King C., et al. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117 2 (2004) 265-277
52. Datta S., and Sarvetnick N.E. IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanisms. PLoS ONE 3 9 (2008) e3118
53. Spolski R., et al. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci U S A 105 37 (2008) 14028-14033
54. Sutherland A.P., et al. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 58 5 (2009) 1144-1155
55. Hernandez-Hoyos G., et al. The lymphopenia mutation of the BB rat causes inappropriate apoptosis of mature thymocytes. Eur J Immunol 29 6 (1999) 1832-1841
56. Jones J.L., et al. IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab Campath-1H). J Clin Invest. [Epub ahead of print] (2009)
57. Shen S., et al. Control of homeostatic proliferation by regulatory T cells. J Clin Invest 115 12 (2005) 3517-3526
58. Brode S., et al. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 177 10 (2006) 6603-6612
59. Askenasy N., et al. Mechanisms of T regulatory cell function. Autoimmun Rev 7 5 (2008) 370-375
60. Bourgeois C., et al. A major role for memory CD4 T cells in the control of lymphopenia-induced proliferation of naive CD4 T cells. J Immunol 174 9 (2005) 5316-5323
61. Chang X., et al. Homeostatic proliferation in the mice with germline FoxP3 mutation and its contribution to fatal autoimmunity. J Immunol 181 4 (2008) 2399-2406
62. McHugh R.S., and Shevach E.M. Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 168 12 (2002) 5979-5983
63. Marrella V., et al. A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest 117 5 (2007) 1260-1269
64. Brusko T., et al. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56 3 (2007) 604-612
65. Martin B., et al. Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo. J Immunol 172 6 (2004) 3391-3398
66. Moxham V.F., et al. Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol 180 6 (2008) 3910-3918
67. Wei S., et al. Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Res 67 15 (2007) 7487-7494
68. Zhang H., et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med 11 11 (2005) 1238-1243
69. Kline J., et al. Homeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of B16 melanoma. Clin Cancer Res 14 10 (2008) 3156-3167
70. Powell Jr. D.J., et al. Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy. J Immunother 30 4 (2007) 438-447
71. Milner J.D., et al. Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models. J Clin Immunol 28 Suppl 1 (2008) S29-33
72. Tang Q., and Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9 3 (2008) 239-244
73. Tang Q., et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28 5 (2008) 687-697
74. Barker B.R., et al. IL-21 induces apoptosis of antigen-specific CD8+ T lymphocytes. J Immunol 179 6 (2007) 3596-3603
75. Massardo L., et al. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation. Lupus 18 6 (2009) 539-546
76. Subra J.F., et al. Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin Exp Immunol 126 3 (2001) 540-544
77. Goyal R., et al. Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders. Curr Opin Rheumatol 21 1 (2009) 78-84
78. Westerberg L.S., et al. Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency - lessons learned from monogenic disorders in mice and men. Curr Opin Immunol 20 6 (2008) 646-654
79. van der Werf N., et al. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 23 3 (2007) 169-183
80. Fontenot J.D., et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 4 (2003) 330-336
81. Hori S., et al. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 5609 (2003) 1057-1061
82. Scheffold A., et al. Competition for cytokines: T(reg) cells take all. Nat Immunol 8 12 (2007) 1285-1287
83. Milner J.D., et al. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proc Natl Acad Sci U S A 104 2 (2007) 576-581
84. Brunkow M.E., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27 1 (2001) 68-73
85. Kim J.M., et al. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8 2 (2007) 191-197
86. Lahl K., et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204 1 (2007) 57-63
87. Mottet C., et al. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170 8 (2003) 3939-3943
88. Sakaguchi S., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 3 (1995) 1151-1164
89. Chang X., et al. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med 202 8 (2005) 1141-1151
90. Chen G.Y., et al. Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. J Immunol 180 8 (2008) 5163-5166
91. Liston A., et al. Lack of Foxp3 function and expression in the thymic epithelium. J Exp Med 204 3 (2007) 475-480